Evidence map›Paper›PMID 38802909›Full record

ArticleZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics2024

[Risk factors for embolism in children with refractory

Li-Na Xie, Te Feng, Yan-Jun Guo, Yu-Hui Zhang, Yuan-Zhe Li, Wan-Cun Zhang

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Biomarkers associated with the diagnosis and prognosis ofFrontiers in cellular and infection microbiology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Li-Na XieDepartment of Respiratory Medicine, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, China.
Te FengDepartment of Respiratory Medicine, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, China.
Yan-Jun GuoDepartment of Respiratory Medicine, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, China.
Yu-Hui ZhangDepartment of Respiratory Medicine, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, China.
Yuan-Zhe LiDepartment of Respiratory Medicine, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, China.
Wan-Cun ZhangDepartment of Respiratory Medicine, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo study the risk factors for embolism in children with refractory

methodsThis retrospective study included 175 children diagnosed with RMPP at Children's Hospital Affiliated toZhengzhou University from January 2019 to October 2023. They were divided into two groups based on the presence of embolism: the embolism group (

resultsMultivariate logistic regression analysis indicated that higher levels of D-dimer, interleukin-6 (IL-6) and neutrophil to lymphocyte ratio (NLR), lung necrosis, and pleural effusion were risk factors for embolism in children with RMPP (

conclusionsHigher levels of D-dimer, IL-6 and NLR, lung necrosis, and pleural effusion are risk factors for embolism in children with RMPP. The nomogram model based on these risk factors has high clinical value for predicting embolism in children with RMPP.

Indexed as

Fibrin Fibrinogen Degradation ProductsInterleukin-6NomogramsPneumonia, MycoplasmaAdolescentChildChild, PreschoolEmbolismFemaleHumansLogistic ModelsMaleNeutrophilsRetrospective StudiesRisk FactorsFibrin Fibrinogen Degradation Productsfibrin fragment DInterleukin-6ChildNomogramPredictive modelRefractory Mycoplasma pneumoniae pneumoniaRisk factor

Identifiers

PMID38802909
PMCPMC11135069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.